semaglutide approval for mash FDA Approves Wegovy® as First Treatment FDA Approves Semaglutide for MASH

This helps us identify any underlying issues that may affect your treatment plan

doi: Jensen MD, Ryan DH, Apovian CM, et al

The interest in using Metformin for weight loss stems from personal experiences and limited clinical studies suggesting that it may help reduce appetite and improve insulin sensitivity, both of which could contribute to weight loss in some individuals

When deciding which weight loss medication is right for you, it's important to consider the average weight loss

While the trial was not designed to formally disentangle weight lossmediated vs weightindependent mechanisms, the magnitude and durability of weight loss likely play a substantial role in risk modification. Clinicians should note that in SELECT, treatment discontinuation due to adverse events was 16% on semaglutide vs 8% on placebo, largely driven by GI events

BMB Reports , 52 (7), 424